BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16453304)

  • 1. Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway.
    Kuo L; Chang HC; Leu TH; Maa MC; Hung WC
    J Cell Physiol; 2006 Jun; 207(3):729-34. PubMed ID: 16453304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
    Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
    Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells.
    Taheri F; Bazan HE
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1931-41. PubMed ID: 17460244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription.
    Pan MR; Hung WC
    J Biol Chem; 2002 Sep; 277(36):32775-80. PubMed ID: 12087091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
    Gum R; Wang H; Lengyel E; Juarez J; Boyd D
    Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
    Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
    Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
    Liu ZM; Huang HS
    Cell Signal; 2006 Feb; 18(2):244-55. PubMed ID: 15961274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
    Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
    Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Src-dependent transactivation of PDGFR contributes to TNF-α-induced MMP-9 expression and functional impairment in osteoblasts.
    Tsai CL; Chen WC; Lee IT; Chi PL; Cheng SE; Yang CM
    Bone; 2014 Mar; 60():186-97. PubMed ID: 24361597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.
    Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z
    Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes.
    Tanaka T; Kanai H; Sekiguchi K; Aihara Y; Yokoyama T; Arai M; Kanda T; Nagai R; Kurabayashi M
    J Mol Cell Cardiol; 2000 Nov; 32(11):1955-67. PubMed ID: 11040101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.
    Hsu MC; Chang HC; Hung WC
    J Biol Chem; 2006 Feb; 281(8):4718-25. PubMed ID: 16377629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular signal-regulated kinase and c-Src, but not Jun N-terminal kinase, are involved in basal and gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone alpha-subunit promoter.
    Harris D; Chuderland D; Bonfil D; Kraus S; Seger R; Naor Z
    Endocrinology; 2003 Feb; 144(2):612-22. PubMed ID: 12538624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic FGF downregulates TSP50 expression via the ERK/Sp1 pathway.
    Wang M; Bao YL; Wu Y; Yu CL; Meng XY; Huang YX; Sun Y; Zheng LH; Li YX
    J Cell Biochem; 2010 Sep; 111(1):75-81. PubMed ID: 20506264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells.
    Hung WC; Chang HC
    J Agric Food Chem; 2009 Jan; 57(1):76-82. PubMed ID: 19061309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
    Chang HC; Liu LT; Hung WC
    Cell Signal; 2004 Jun; 16(6):675-9. PubMed ID: 15093608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells.
    Sroka IC; Nagle RB; Bowden GT
    Neoplasia; 2007 May; 9(5):406-17. PubMed ID: 17534446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.